Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$105,437
+$29,968 QoQ
Shares Held
419
+20.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#4,020
of 4,153 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HIGHLINE WEALTH PARTNERS LLC holds $1,353,065 across 14 Drug Manufacturers - General names. ABBV ranks #5 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,635 | $415,240 | |
| 2 | LLY |
ELI LILLY & Co
|
180 | $215,897 | |
| 3 | AMGN |
Amgen Inc
|
429 | $155,349 | |
| 4 | MRK |
Merck & Co., Inc.
|
932 | $119,762 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
419 | $105,437 | |
| 6 | AZN |
Astrazeneca PLC
|
314 | $59,540 | |
| 7 | PFE |
Pfizer Inc
|
2,356 | $56,732 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
446 | $56,347 |
All Filings in ABBV
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $105,437 | 419 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $75,469 | 347 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $73,573 | 322 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $67,146 | 290 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $26,729 | 144 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $26,609 | 127 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $13,505 | 76 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $15,995 | 81 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $12,864 | 75 | Shares | Sole | 2024-10-28 | |
| 2024-03-31 | $12,564 | 69 | Shares | Sole | 2024-10-28 | |
| 2023-12-31 | $10,692 | 69 | Shares | Sole | 2024-10-29 | |
| 2023-09-30 | $17,589 | 118 | Shares | Sole | 2024-10-29 | |
| 2023-06-30 | $9,296 | 69 | Shares | Sole | 2024-10-29 | |
| 2023-03-31 | $12,590 | 79 | Shares | Sole | 2024-10-29 | |
| 2022-12-31 | $12,282 | 76 | Shares | Sole | 2024-10-29 | |
| 2022-09-30 | $10,199 | 76 | Shares | Sole | 2024-10-29 | |
| No filing history on record for this holder in this stock. | ||||||